第四型P型ATPases:癌症发展,进展和治疗的最新更新
Eugenia M Yazlovitskaya1, Todd R Graham1
1Department of Biological Sciences, Vanderbilt University, Nashville, TN 37232, USA.
Cancers
|September 9, 2023
概括
癌细胞改变脂质代谢和膜组成,影响生存. 第四类P型ATPases (P4-ATPases) 调节膜不对称性,并与癌症进展有关,提供潜在的治疗点.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 癌细胞表现出了显著的生存适应性,包括改变的脂质代谢和不规则的细胞膜组成.
- 正常的细胞膜表现出明显的脂不对称性,由脂酶调节,主要是IV型P型ATP酶 (P4-ATPases).
- 功能失调的P4-ATPases破坏了膜组织,导致被认为是癌症生物标志物的变化,例如酸胺错位化.
研究的目的:
- 审查最近关于P4-ATPases在癌症发展和进展中的作用的文献.
- 讨论针对P4-ATPases作为一种新的抗癌治疗策略的潜力.
主要方法:
- 对最近出版的文献评论.
- 对研究P4-ATPase在各种癌症类型中的功能进行分析.
- 讨论针对P4-ATPases的治疗前景.
主要成果:
- P4-ATPases在各种癌症的发展和进展中发挥着重要作用.
- P4-ATPase功能的改变与膜脂质不对称的变化有关.
- 特定的脂质变化,比如那些涉及脂素,作为癌症生物标志物.
结论:
- P4-ATPases是膜不对称性的关键调节者,并与癌症病原发生有关.
- 向P4-ATPases代表了未来抗癌治疗的有希望的途径.
- 对癌症中P4-ATPase机制的进一步研究是有必要的.
相关概念视频
ATP Driven Pumps III: V-type Pumps
3.8K
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
3.8K
ATP Driven Pumps II: P-type Pumps
4.9K
The P-type pumps are a large family of integral membrane transporter ATPases. They are divided into five major types based on substrate specificity, from I to V.
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
4.9K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
ATP Driven Pumps I: An Overview
8.2K
ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
8.2K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K


